TPO Receptor Agonists
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia (NCT06613880) | Institute of Hematology & Blood Diseases Hospital, China | 2024-10-24 |
Track TPO Receptor Agonists automatically
Every clearance here is in the API, with alerts when new ones post.